The Misuse of Drugs Regulations (Northern Ireland) 2002

Marking of bottles and other containers

18.—(1) Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—

(a) in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;

(b) in the case of a controlled drug which is a preparation—

(i) made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;

(ii) not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.

(2) Nothing in this regulation shall have effect in relation to—

(a) the drugs specified in Schedules 4 and 5 or poppy-straw;

(b) any drug specified in Schedule 3 contained in or comprising a preparation which—

(i) is required for use as a buffering agent in chemical analysis;

(ii) has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and

(iii) is premixed in a kit;

(c) any exempt product;

(d) the supply of a controlled drug by or on the prescription of a practitioner;

(e) the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.

(3) In this regulation, the expressions “clinical trial” and “medicinal test on animals” have the same meanings as in the Medicines Act 1968.